100
Participants
Start Date
May 1, 2025
Primary Completion Date
May 1, 2026
Study Completion Date
May 1, 2026
Observational
In a cohort of patients treated with duloxetine for fibromyalgia, participants vitals signs (blood pressure, heart rate, oxygen saturation level, temperature) will be taken as well as height and weight. Participants will fill out a questionnaire regarding their fibromyalgia diagnosis and symptoms. Lastly, participants will complete two sets of blood samples. One blood sample will evaluate genetic variants for duloxetine metabolizing capacity. The other sample will be used to analyze the level of concentration of duloxetine.
RECRUITING
Pain Management Center and Pain Research Center at the University of Utah, Salt Lake City
University of Utah
OTHER